Aquestive Therapeutics Inc (AQST)

3.52 -0.07 (-1.95%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Aquestive Therapeutics Max Drawdown (5Y): 96.68% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for AQST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Eli Lilly and Co 24.12%
Rockwell Medical Inc 98.87%
Omeros Corp 95.41%
Cormedix Inc 95.24%
Axogen Inc 90.41%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -45.63
Beta (5Y) 2.625
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 114.2%
Historical Sharpe Ratio (5Y) -0.0925
Historical Sortino (5Y) -0.2346
Monthly Value at Risk (VaR) 5% (5Y Lookback) 37.27%